The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2)

DNA and Cell Biology

Volumn 26, Issue 8, 2007, Pages 589-597

  Svensson, Emelie ^a   Vidovic, Karina ^a   Olofsson, Tor ^a   Vallon Christersson, Johan ^a   Borg, Åke ^a   Gullberg, Urban ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN U937; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NRDG2 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UMBILICAL CORD BLOOD;

ALTERNATIVE SPLICING; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENES, WILMS TUMOR; HEMATOPOIETIC STEM CELLS; HUMANS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 34547899857     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0586     Document Type: Article

References (46)

1. Algar, E.M., Khromykh, T., Smith, S.I., Blackburn, D.M., Bryson, G.J., and Smith, P.J. (1996). A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12, 1005-1014.
2. Bengtsson, H., Jonsson, G., and Vallon-Christersson, J. (2004). Calibration and assessment of channel-specific biases in microarray data with extended dynamical range. BMC Bioinformatics 5, 177.
3. Boulkroun, S., Fay, M., Zennaro, M.C., Escoubet, B., Jaisser, F., Blot-Chabaud, M., Farman, N., and Courtois-Coutry, N. (2002). Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem 277, 31506-31515.
4. Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., et al. (1990). Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' Tumor locus. Cell 60, 509-520.
5. Choi, S.C., Kim, K.D., Kim, J.T., Kim, J.W., Yoon, D.Y., Choe, Y.K., Chang, Y.S., Paik, S.G., and Lim, J.S. (2003). Expression and regulation Of NDRG2 (N-Myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett 553, 413-418.
6. Chylicki, K., Ehinger, M., Svedberg, H., Bergh, G., Olsson, I., and Gullberg, U. (2000). P53-mediated differentiation of the erythroleukemia cell line K562. Cell Growth Differ 11, 315-324.
7. Deng, Y., Yao, L., Chau, L., Ng, S.S., Peng, Y., Liu, X., Au, W.S., Wang, J., Li, F., Ji, S., Han, H., Nie, X., Li, Q., Kung, H.F., Leung, S.Y., and Lin, M.C. (2003). N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 106, 342-347.
8. Discenza, M.T., and Pelletier, J. (2004). Insights into the physiological role of WT1 from studies of genetically modified mice. Physiol Genomics 16, 287-300.
9. + human marrow cells in vitro. Br J Haematol 127, 451-463.
10. Ellisen, L.W., Carlesso, N., Cheng, T., Scadden, D.T., and Haber, D.A. (2001). The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J 20, 1897-1909.
11. Elmaagacli, A.H., Koldehoff, M., Peceny, R., Klein-Hitpass, L., Ottinger, H., Beelen, D.W., and Opalka, B. (2005). WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica 90, 326-334.
12. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H., and Bruns, G.A. (1990). Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343, S774-S778.
13. Ginzinger, D.G. (2002). Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30, 503-512.
14. Herzer, U., Crocoll, A., Barton, D., Howells, N., and Englert, C. (1999). The Wilms tumor suppressor gene Wt1 is required for development of the spleen. Curr Biol 9, 837-840.
15. + haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Br J Haematol 116, 409-420.
16. Hu, X.L., Liu, X.P., Deng, Y.C., Lin, S.X., Wu, L., Zhang, J., Wang, L.F., Wang, X.B., Li, X., Shen, L., Zhang, Y.Q., and Yao, L.B. (2006). Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues. Cell Tissue Res 325, 67-76.
17. Inoue, K., Tamaki, H., Ogawa, H., Oka, Y., Soma, T., Tatekawa, T., Oji, Y., Tsuboi, A., Kim, E.H., Kawakami, M., Akiyama, T., Kishimoto, T., and Sugiyama, H. (1998). Wilms' tumor gene (WT1) competes with differentiation- inducing signal in hematopoietic progenitor cells. Blood 91, 2969-2976.
18. Kalaydjieva, L., Gresham, D., Gooding, R., Heather, L., Baas, F., de Jonge, R., Blechschmidt, K., Angelicheva, D., Chandler, D., Worsley, P., Rosenthal, A., King, R.H., and Thomas, P.K. (2000). N-Myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67, 47-58.
19. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. (1993). WT-1 is required for early kidney development. Cell 74, 679-691.
20. Kurdistani, S.K., Arizti, P., Reimer, C.L., Sugrue, M.M., Aaronson, S.A., and Lee, S.W. (1998). Inhibition of tumor cell growth by RTP/Rit42 and its responsiveness to P53 and DNA damage. Cancer Res 58, 4439-4444.
21. Lee, S.B., and Haber, D.A. (2001). Wilms tumor and the WT1 gene. Exp Cell Res 264, 74-99.
22. Loeb, D.M., Summers, J.L., Burwell, E.A., Korz, D., Friedman, A.D., and Sukumar, S. (2003). An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation. Leukemia 17, 965-971.
23. Moore, A.W., McInnes, L., Kreidberg, J., Hastie, N.D., and Schedl, A. (1999). YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126, 1845-1857.
24. Nakagama, H., Heinrich, G., Pelletier, J., and Housman, D.E. (1995). Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 15, 1489-1498.
25. Nishida, S., Hosen, N., Shirakata, T., Kanato, K., Yanagihara, M., Nakatsuka, S.I., Hoshida, Y., Nakazawa, T., Harada, Y., Tatsumi, N., Tsuboi, A., Kawakami, M., Oka, Y., Oji, Y., Aozasa, K., Kawase, I., and Sugiyama, H. (2006). AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with Wilms' tumor gene, WT1. Blood 107, 3303-3312.
26. Okuda, T., and Kondoh, H. (1999). Identification of new genes Ndr2 and Ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-Myc. Biochem Biophys Res Commun 266, 208-215.
27. Piquemal, D., Joulia, D., Balaguer, P., Basset, A., Marti, J., and Commes, T. (1999). Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta 1450, 364-373.
28. Qu, X., Zhai, Y., Wei, H., Zhang, C., Xing, G., Yu, Y., and He, F. (2002). Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229, 35-44.
29. Rao, M.K., Pham, J., Imam, J.S., MacLean, J.A., Murali, D., Furuta, Y., Sinha-Hikim, A.P., and Wilkinson, M.F. (2006). Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. Genes Dev 20, 147-152.
30. Rauscher, F.J., 3rd, Morris, J.F., Tournay, O.E., Cook, D.M., and Curran, T. (1990). Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250, 1259-1262.
31. Saal, L.H., Troein, C., Vallon-Christersson, J., Gruvberger, S., Borg, A., and Peterson, C. (2002). Bioarray software environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 3, SOFTWARE0003.
32. Scharnhorst, V., van der Eb, A.J., and Jochemsen, A.G. (2001). WT1 proteins: functions in growth and differentiation. Gene 273, 141-161.
33. Shimono, A., Okuda, T., and Kondoh, H. (1999). N-Myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-Myc mutant. Mech Dev 83, 39-52.
34. Smith, S.I., Weil, D., Johnson, G.R., Boyd, A.W., and Li, C.L. (1998). Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells. Blood 91, 764-773.
35. Svedberg, H., Chylicki, K., Baldetorp, B., Rauscher, F.J., 3rd, and Gullberg, U. (1998). Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene 16, 925-932.
36. Svedberg, H., Richter, J., and Gullberg, U. (2001). Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells. Leukemia 15, 1914-1922.
37. Svensson, E., Eriksson, H., Gekas, C., Olofsson, T., Richter, J., and Gullberg, U. (2005). DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis. Exp Cell Res 308, 211-221.
38. Tsuboi, A., Oka, Y., Ogawa, H., Elisseeva, O.A., Tamaki, H., Oji, Y., Kim, E.H., Soma, T., Tatekawa, T., Kawakami, M., Kishimoto, T., and Sugiyama, H. (1999). Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk Res 23, 499-505.
39. Ulrix, W., Swinnen, J.V., Heyns, W., and Verhoeven, G. (1999). The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455, 23-26.
40. van Belzen, N., Dinjens, W.N., Diesveld, M.P., Groen, N.A., van der Made, A.C., Nozawa, Y., Vlietstra, R., Trapman, J., and Bosman, F.T. (1997). A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77, 85-92.
41. Wagner, K.D., Wagner, N., Vidal, V.P., Schley, G., Wilhelm, D., Schedl, A., Englert, C., and Scholz, H. (2002). The Wilms' tumor gene wt1 is required for normal development of the retina. EMBO J 21, 1398-1405.
42. Wagner, N., Wagner, K.D., Hammes, A., Kirschner, K.M., Vidal, V.P., Schedl, A., and Scholz, H. (2005). A splice variant of the Wilms' tumour suppressor WT1 is required for normal development of the olfactory system. Development 132, 1327-1336.
43. Wang, Z.Y., Qiu, Q.Q., Enger, K.T., and Deuel, T.F. (1993). A second transcriptionally active DNA-binding site for the Wilms' tumor gene product, WT1. Proc Natl Acad Sci USA 90, 8896-8900.
44. Xu, B., Lin, L., and Rote, N.S. (1999). Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. Biol Reprod 61, 681-686.
45. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., and Maekawa, T. (1996). Growth inhibition of human leukemic cells by WT1 (Wilms' tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87, 2878-2884.
46. Yang, I.V., Chen, E., Hasseman, J.P., Liang, W., Frank, B.C., Wang, S., Sharov, V., Saeed, A.I., White, J., Li, J., Lee, N.H., Yeatman, T.J., and Quackenbush, J. (2002). Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol 3, Research0062.